<DOC>
	<DOCNO>NCT00893594</DOCNO>
	<brief_summary>This double-blinded placebo study , examine efficacy Sumatriptan Naprosyn treatment migraine aura .</brief_summary>
	<brief_title>Efficacy Sumatriptan With Naprosyn Migraine With Aura</brief_title>
	<detailed_description />
	<mesh_term>Migraine Disorders</mesh_term>
	<mesh_term>Migraine Aura</mesh_term>
	<mesh_term>Sumatriptan</mesh_term>
	<mesh_term>Naproxen</mesh_term>
	<criteria>Subjects must 18 50 year age , inclusive . Patients meet International Headache Society ( IHS ) classification criterion migraine aura . Subjects must carry diagnosis 12 migraine aura per month least three month study inclusion . migraine aura include study Subjects must onset visual aura occur 1530 minute migraine headache . Subjects must able understand complete migraine diary . Subjects must able distinguish migraine aura type headache . Subjects must generally good health confirm medical medication history , baseline physical neurological exam vital sign . Female subject must either ) postmenopausal one year , b ) surgically sterile , c ) practice acceptable birth control least one month prior screen throughout study , ) practice abstinence agree continue throughout study . Subjects significant systemic disease migraine equally painful painful . Subjects progressive neurological disorder . Subjects 8 migraine 15 headache day per month . Subjects previously take Treximet fail due lack efficacy adverse side effect . Subjects carry diagnosis chronic tension type headache cluster headache base International Headache Society criterion . Subject receive investigative drug within 3 month prior enrollment study . Subject diagnosis seizure disorder , chronic daily headache , uncontrolled hypertension , cardiovascular disease , history stroke , basilar hemiplegic migraine , hepatic disease , active peptic ulcer disease . Subjects currently take 3 month prior study , use prophylactic migraine medication . Subjects know allergy Sumatriptan Naprosyn . Subjects opinion Dr. Mechtler condition enrol study .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>50 Years</maximum_age>
	<verification_date>February 2015</verification_date>
	<keyword>migraine</keyword>
	<keyword>migraine aura</keyword>
	<keyword>headache</keyword>
</DOC>